147 related articles for article (PubMed ID: 35442150)
1. Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study.
Bennani FE; Doudach L; Karrouchi K; Tarib A; Rudd CE; Ansar M; Faouzi MEA
J Biomol Struct Dyn; 2023 Jun; 41(9):4194-4218. PubMed ID: 35442150
[TBL] [Abstract][Full Text] [Related]
2. In Silico Identification of Promising New Pyrazole Derivative-Based Small Molecules for Modulating CRMP2, C-RAF, CYP17, VEGFR, C-KIT, and HDAC-Application towards Cancer Therapeutics.
Bennani FE; Karrouchi K; Doudach L; Scrima M; Rahman N; Rastrelli L; Tallei TE; Rudd CE; Faouzi MEA; Ansar M
Curr Issues Mol Biol; 2022 Oct; 44(11):5312-5351. PubMed ID: 36354673
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anticancer activity, molecular docking and molecular dynamics studies of some pyrazole-chalcone hybrids.
Al Otaibi AA; Alshammari SL; Dhahi Alsukaibi AK; Jamal A; Rajendrasozhan S; Alenezi KM; Hussain A; Khan I; Mushtaque M; Haque A
J Biomol Struct Dyn; 2024; 42(3):1381-1391. PubMed ID: 37071766
[TBL] [Abstract][Full Text] [Related]
4. 'Synthesis, antiviral activity, molecular docking, and molecular dynamics studies of ethoxy phthalimide pyrazole derivatives against Cytomegalovirus and Varicella-Zoster virus: potential consequences and strategies for developing new antiviral treatments'.
Verma AK; Yadav V; Bhojiya AA; Upadhyay SK; Singh N; Pareek SS; Ashid M; Ahmed SF; Hossain MS
J Biomol Struct Dyn; 2023 Nov; ():1-20. PubMed ID: 37965748
[TBL] [Abstract][Full Text] [Related]
5. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, in vitro and in silico evaluation of anti-colorectal cancer activity of curcumin analogues containing 1,3-diphenyl-1H-pyrazole targeting EGFR tyrosine kinase.
Doan NQH; Nguyen NTK; Nguyen NB; Tran TT; Tran QN; Truong TN
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130414. PubMed ID: 37331408
[TBL] [Abstract][Full Text] [Related]
7. New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis,
Yaseen YS; Mahmood AAR; Abbas AH; Shihab WA; Tahtamouni LH
Med Chem; 2023; 19(5):445-459. PubMed ID: 36537605
[TBL] [Abstract][Full Text] [Related]
8.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
9. Designing of benzothiazole derivatives as promising EGFR tyrosine kinase inhibitors: a pharmacoinformatics study.
Shahare HV; Talele GS
J Biomol Struct Dyn; 2020 Mar; 38(5):1365-1374. PubMed ID: 30955452
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
Abdizadeh R; Hadizadeh F; Abdizadeh T
J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors.
Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Firdaus JU; Rahman S; Jha M; Sheikh AA
Anticancer Agents Med Chem; 2021; 21(1):42-60. PubMed ID: 32718297
[TBL] [Abstract][Full Text] [Related]
12. Identification of potent EGFR-TKD inhibitors from NPACT database through combined computational approaches.
Mir SA; Muhammad A; Padhiary A; Ekka NJ; Baitharu I; Naik PK; Nayak B
J Biomol Struct Dyn; 2023; 41(21):12063-12076. PubMed ID: 36695102
[TBL] [Abstract][Full Text] [Related]
13. Molecular interaction study of novel indoline derivatives with EGFR-kinase domain using multiple computational analysis.
Palanivel S; Yli-Harja O; Kandhavelu M
J Biomol Struct Dyn; 2022 Oct; 40(16):7545-7554. PubMed ID: 33749517
[TBL] [Abstract][Full Text] [Related]
14. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
[TBL] [Abstract][Full Text] [Related]
15. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, evaluation, molecular dynamics simulation and targets identification of novel pyrazole-containing imide derivatives.
Cai W; Wu J; Sun Y; Liu A; Wang R; Ma Y; Shuqing Wang ; Dong W
J Biomol Struct Dyn; 2021 Apr; 39(6):2176-2188. PubMed ID: 32189577
[TBL] [Abstract][Full Text] [Related]
17. Pyrazole based Furanone Hybrids as Novel Antimalarial: A Combined Experimental, Pharmacological and Computational Study.
Choudhary D; Rani I; Monga J; Goyal R; Husain A; Garg P; Khokra SL
Cent Nerv Syst Agents Med Chem; 2022; 22(1):39-56. PubMed ID: 35232355
[TBL] [Abstract][Full Text] [Related]
18. Development of pyrolo[2,3-c]pyrazole, pyrolo[2,3-d]pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological evaluation and molecular dynamics investigations.
Azmy EM; Hagras M; Ewida MA; Doghish AS; Gamil Khidr E; El-Husseiny AA; Gomaa MH; Refaat HM; Ismail NSM; Nassar IF; Lashin WH
Bioorg Chem; 2023 Oct; 139():106729. PubMed ID: 37467621
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
20. The potential of some functional group compounds substituted 8-Manzamine A as RSK1 inhibitors: molecular docking and molecular dynamics simulations.
Zayed AOH; Altarabeen M; AlShamaileh E; Zain SM
J Biomol Struct Dyn; 2024 Feb; ():1-10. PubMed ID: 38319051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
